Home › NDC Lookup › RxCUI directory › RxCUI 730869

Amlodipine 5 MG / olmesartan medoxomil 20 MG Oral Tablet — RxCUI 730869

RxNorm drug concept · Semantic clinical drug
RxCUI 730869 Semantic clinical drug · SCD ● Current RxNorm concept 58 FDA products 127 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI730869
Official nameAmlodipine 5 MG / olmesartan medoxomil 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamlodipine 5 MG (as amlodipine besylate 6.9 MG) / olmesartan medoxomil 20 MG Oral Tablet
FDA products mapped58
Package NDCs mapped127
Reported Medicaid activity (SDUD)69,457 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Olmesartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Olmesartan is used to treat high blood pressure (hypertension) in adults and in kids as young as six years old. It works by relaxing your blood vessels so your heart doesn't have t...
  • No — this is one of the most important things to know about olmesartan. It can cause very serious harm to an unborn baby, including kidney failure and even death, especially after...
  • Can I take this if I'm pregnant or trying to get pregnant?
  • Dizziness is the most commonly reported side effect — it happens in about 3 out of 100 people in clinical trials. It's most likely when you first start the medicine, especially if...
📖 Read our full Olmesartan guide →

🕸️ Concept Web — How Amlodipine 5 MG / olmesartan medoxomil 20 MG Ora... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amlodipine 5 MG / olmesartan medoxomil 20 MG Oral Tablet RxCUI 730869

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Amlodipine 17767
    • Olmesartan 321064
    • Amlodipine / olmesartan 1009015
    • Olmesartan medoxomil 118463
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Azor 730862
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amlodipine / olmesartan Oral Tablet 730860
    • Amlodipine / olmesartan medoxomil Oral Tablet 2648326
    • Amlodipine / olmesartan Oral Product 1152285
    • Amlodipine / olmesartan Pill 1152286
    • Amlodipine / olmesartan medoxomil Oral Product 2660099
    • Amlodipine / olmesartan medoxomil Pill 2661386
    • Amlodipine / olmesartan Oral Tablet [Azor] 744623
    • Amlodipine / olmesartan medoxomil Oral Tablet [Azor] 2656124
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amlodipine 5 MG SCDC · 329528
  • Olmesartan medoxomil 20 MG SCDC · 358775
  • Amlodipine / olmesartan Oral Tablet SCDF · 730860
  • Amlodipine / olmesartan medoxomil Oral Tablet SCDFP · 2648326
  • Amlodipine / olmesartan Oral Product SCDG · 1152285
  • Amlodipine / olmesartan Pill SCDG · 1152286
  • Amlodipine / olmesartan medoxomil Oral Product SCDGP · 2660099
  • Amlodipine / olmesartan medoxomil Pill SCDGP · 2661386

Brand-Name Concepts

  • Amlodipine 5 MG / olmesartan medoxomil 20 MG Oral Tablet [Azor] SBD · 744632
  • Amlodipine 5 MG / olmesartan medoxomil 20 MG [Azor] SBDC · 744630
  • Amlodipine / olmesartan Oral Tablet [Azor] SBDF · 744623
  • Amlodipine / olmesartan medoxomil Oral Tablet [Azor] SBDFP · 2656124
  • Azor Oral Product SBDG · 1166087
  • Azor Pill SBDG · 1166088
  • Azor BN · 730862

📦 FDA Products & Package NDCs

58 products · 127 package NDCs
127 package NDCs map to RxCUI 730869 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00713-0870-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0870-30) Azor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0871-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0871-30) Azor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0872-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0872-30) Azor Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0873-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0873-30) Azor Cosette Pharmaceuticals, Inc. 2022-09-01
27241-0083-03 30 TABLET in 1 BOTTLE (27241-083-03) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0083-09 90 TABLET in 1 BOTTLE (27241-083-09) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0084-03 30 TABLET in 1 BOTTLE (27241-084-03) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0084-09 90 TABLET in 1 BOTTLE (27241-084-09) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0085-03 30 TABLET in 1 BOTTLE (27241-085-03) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0085-09 90 TABLET in 1 BOTTLE (27241-085-09) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0086-03 30 TABLET in 1 BOTTLE (27241-086-03) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
27241-0086-09 90 TABLET in 1 BOTTLE (27241-086-09) Amlodipine besylate and Olmesartan medoxomil Ajanta Pharma USA Inc. 2017-02-06
31722-0445-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-445-30) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0445-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-445-90) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0446-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-446-30) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0446-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-446-90) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0447-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-447-30) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0447-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-447-90) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0448-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-448-30) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
31722-0448-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-448-90) Amlodipine and Olmesartan Medoxomil Camber Pharmaceuticals, Inc. 2025-02-14
33342-0190-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-190-07) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0190-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-190-10) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0190-12 10 BLISTER PACK in 1 CARTON (33342-190-12) / 10 TABLET, FIL... AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0190-44 1000 TABLET, FILM COATED in 1 BOTTLE (33342-190-44) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0191-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-191-07) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0191-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-191-10) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0191-12 10 BLISTER PACK in 1 CARTON (33342-191-12) / 10 TABLET, FIL... AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0191-44 1000 TABLET, FILM COATED in 1 BOTTLE (33342-191-44) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0192-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-192-07) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0192-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-192-10) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0192-12 10 BLISTER PACK in 1 CARTON (33342-192-12) / 10 TABLET, FIL... AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0192-44 1000 TABLET, FILM COATED in 1 BOTTLE (33342-192-44) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0193-07 30 TABLET, FILM COATED in 1 BOTTLE (33342-193-07) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0193-10 90 TABLET, FILM COATED in 1 BOTTLE (33342-193-10) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0193-12 10 BLISTER PACK in 1 CARTON (33342-193-12) / 10 TABLET, FIL... AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
33342-0193-44 1000 TABLET, FILM COATED in 1 BOTTLE (33342-193-44) AMLODIPINE and OLMESARTAN medoxomil Macleods Pharmaceuticals Limited 2016-10-27
42291-0001-30 30 TABLET, FILM COATED in 1 BOTTLE (42291-001-30) Amlodipine and Olmesartan Medoxomil AvKARE 2024-06-18
42291-0002-30 30 TABLET, FILM COATED in 1 BOTTLE (42291-002-30) Amlodipine and Olmesartan Medoxomil AvKARE 2024-06-18
42291-0003-30 30 TABLET, FILM COATED in 1 BOTTLE (42291-003-30) Amlodipine and Olmesartan Medoxomil AvKARE 2024-06-18
42291-0004-30 30 TABLET, FILM COATED in 1 BOTTLE (42291-004-30) Amlodipine and Olmesartan Medoxomil AvKARE 2024-06-18
42571-0235-05 500 TABLET in 1 BOTTLE (42571-235-05) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0235-10 1000 TABLET in 1 BOTTLE (42571-235-10) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0235-30 30 TABLET in 1 BOTTLE (42571-235-30) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0235-90 90 TABLET in 1 BOTTLE (42571-235-90) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0236-05 500 TABLET in 1 BOTTLE (42571-236-05) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0236-10 1000 TABLET in 1 BOTTLE (42571-236-10) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0236-30 30 TABLET in 1 BOTTLE (42571-236-30) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0236-90 90 TABLET in 1 BOTTLE (42571-236-90) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0237-05 500 TABLET in 1 BOTTLE (42571-237-05) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
42571-0237-10 1000 TABLET in 1 BOTTLE (42571-237-10) AMLODIPINE AND OLMESARTAN MEDOXOMIL Micro Labs Limited 2018-01-01
Observed labelers: Macleods Pharmaceuticals Limited (16) · Micro Labs Limited (16) · Alembic Pharmaceuticals Inc. (12) · Alembic Pharmaceuticals Limited (12) · Glenmark Pharmaceuticals Inc., USA (12) · ScieGen Pharmaceuticals, Inc (12) · +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.